MLchartDataset catalogue

tabalumab

Term · Oncology and biomedicine · MLC-T-ONC-016955

A human IgG4 monoclonal antibody against B-cell activating factor (BAFF), with potential immunomodulating and antineoplastic activities. Tabalumab binds to and inhibits the activity of both soluble and cell surface-bound BAFF. This may reduce the activity, proliferation and survival of B-cells. A dysregulated expression of BAFF, a member of the tumor necrosis factor (TNF) family of proteins, is often seen in certain autoimmune diseases and certain cancers, and may promote B lymphocyte activation, proliferation and survival.

Table 1. Record
IdentifierMLC-T-ONC-016955
FieldOncology and biomedicine
Synonymsanti-BAFF monoclonal antibody LY2127399
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016955",
  "term": "tabalumab",
  "field": "Oncology and biomedicine",
  "definition": "A human IgG4 monoclonal antibody against B-cell activating factor (BAFF), with potential immunomodulating and antineoplastic activities. Tabalumab binds to and inhibits the activity of both soluble and cell surface-bound BAFF. This may reduce the activity, proliferation and survival of B-cells. A dysregulated expression of BAFF, a member of the tumor necrosis factor (TNF) family of proteins, is often seen in certain autoimmune diseases and certain cancers, and may promote B lymphocyte activation, proliferation and survival.",
  "synonyms": [
    "anti-BAFF monoclonal antibody LY2127399"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/tabalumab/"
}

Record 15,925 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.